Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration.

This article has no abstract
Epistemonikos ID: a574353993c2cf92aeb7cc6c2a1163c652dd33df
First added on: Feb 13, 2025